Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06284122
Status:
RECRUITING
Last Update Posted:
2024-05-20
First Post:
2024-02-14
Brief Title:
Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body Chemotherapy in Follicular Lymphoma FLIPI2-5
Sponsor:
The Lymphoma Academic Research Organisation
Organization:
The Lymphoma Academic Research Organisation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Follicular Lymphoma |
Keywords: